A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
Sooriakumaran, P, Macanas-Pirard, P, Bucca, G, Henderson, A, Langley, SE, Laing, RW, Smith, CP, Laing, EE and Coley, HM (2009) A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. Cancer Genomics Proteomics, 6 (2). 93 - 99. ISSN 1109-6535
Available under License : See the attached licence file.
Official URL: http://cgp.iiarjournals.org/content/6/2/93.short
We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis.
|Additional Information:||Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. Reproduced here by permission of the publisher.|
|Uncontrolled Keywords:||Base Sequence, Cyclooxygenase Inhibitors, DNA Primers, DNA, Complementary, Gene Expression Profiling, Humans, Male, Oligonucleotide Array Sequence Analysis, Polymerase Chain Reaction, Prostatic Neoplasms, Pyrazoles, Single-Blind Method, Sulfonamides|
|Divisions:||Faculty of Health and Medical Sciences > Microbial and Cellular Sciences|
|Deposited By:||Symplectic Elements|
|Deposited On:||23 Apr 2012 09:43|
|Last Modified:||16 Feb 2013 15:48|
Repository Staff Only: item control page